LEDERLE’s ONE-A-DAY BETA BLOCKER ZEBETA (BISOPROLOL) APPROVED ON JULY 31 FOR HYPERTENSION; LABELING INDICATES SAFETY/EFFICACY IN ELDERLY AND BLACK POPULATIONS
• By The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
